The Psychedelic That’s Changing Lives: Addiction, Anxiety, Depression, Neurodegenerative Diseases & More

What if one psychedelic plant could change how we approach trauma, addiction, and even neurodegenerative diseases?

In this eye-opening episode of Keeping It Real, Jillian sits down with Bryan Hubbard, a leading voice in the psychedelic therapy space, to explore the power of Ibogaine therapy.

Together, they take a deep dive into:

• How ibogaine works in the brain to disrupt addiction cycles, rewire trauma pathways, and stimulate neuroplasticity to help people with everything from sobriety to weight loss.
• The powerful potential of ibogaine therapy to address depression, anxiety, PTSD, and stress-related illness
• Why ibogaine may offer hope for those experiencing cognitive decline, and how it's being studied for conditions like Parkinson’s disease, multiple sclerosis (MS), and Lyme disease
• The recent Stanford University–Ambio study, published in Nature Medicine, showing remarkable improvements in veterans with traumatic brain injuries — and no serious adverse events
• Why veterans, trauma survivors, and chronic illness patients are turning to alternative, plant-based healing modalities

While ibogaine therapy remains unapproved by the FDA and is only legal in certain countries, this episode brings awareness to a growing global movement pushing the boundaries of how we understand and treat human suffering.

Disclaimer: This episode is for educational and informational purposes only. Ibogaine is not FDA-approved and should not be considered medical advice. Always consult with a qualified healthcare provider.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.